ClinicalTrials.govpublic full text
Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b
relapsing-remitting multiple sclerosis, multi-center, randomized, prospective, parallel-group, rater-blinded, rr-ms, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 902631
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.